US Broker Ratings

West Pharmaceutical Services, Inc. (WST) Investor Outlook: Navigating a 26.85% Potential Upside

West Pharmaceutical Services, Inc. (NYSE: WST), a stalwart in the healthcare sector, specializes in medical instruments and supplies, with a market capitalization of $19.61 billion. Headquartered..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a 3.38% Potential Upside in Healthcare

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a leading player in the global pharmaceutical industry, continues to attract investor attention with its robust market presence and promising..

Tempus AI, Inc. (TEM) Stock Analysis: Unveiling a 39.88% Potential Upside in Healthcare Tech

Tempus AI, Inc. (NASDAQ: TEM) is a burgeoning player in the healthcare technology sector, with a focus on providing cutting-edge health information services. Based in Chicago,..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A 23.47% Potential Upside in the Healthcare Sector

Neurocrine Biosciences, Inc. (NBIX), a prominent name in the healthcare sector, specifically within the niche of drug manufacturers focusing on specialty and generic pharmaceuticals, offers intriguing..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 4.74% Upside Potential in the Medical Instruments Sector

Intuitive Surgical, Inc. (NASDAQ: ISRG) stands as a formidable entity in the healthcare sector, particularly in the medical instruments and supplies industry. With a staggering market..

DaVita Inc. (DVA) Stock Analysis: Unveiling a Potential 25% Upside for Savvy Investors

DaVita Inc. (DVA), a leading provider in the healthcare sector, focuses on kidney dialysis services, catering primarily to patients with chronic kidney failure. With a market..

Gilead Sciences, Inc. (GILD) Stock Analysis: Exploring a 6.51% Upside and Robust Dividend Yield

Gilead Sciences, Inc. (NASDAQ: GILD) stands out as a formidable player in the healthcare sector, with a focus on addressing unmet medical needs through its innovative..

Avantor, Inc. (AVTR) Stock Analysis: Evaluating Growth Potential Amidst a Challenging Market

Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, presents a complex investment landscape for individual..

Insulet Corporation (PODD) Stock Analysis: A 30% Upside Potential with Strong Buy Ratings

Insulet Corporation (PODD), a key player in the healthcare sector specializing in innovative medical devices, presents a compelling investment opportunity for those interested in the fast-evolving..

Investor Outlook: Encompass Health Corporation (EHC) Offers Compelling 31.90% Upside Potential

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is capturing investor attention with its robust..

Centene Corporation (CNC) Stock Analysis: Navigating Healthcare Opportunities with a 3.57% Upside Potential

Centene Corporation (NYSE: CNC), a prominent player within the healthcare sector, is uniquely positioned in the U.S. healthcare plans industry. With a market capitalization of $19.18..

Solventum Corporation (SOLV)

⚠️ No article content returned.

..

Baxter International Inc. (BAX) Stock Analysis: Exploring a 24.82% Potential Upside in the Healthcare Sector

Baxter International Inc. (NYSE: BAX), a prominent player in the healthcare sector, is capturing investor attention due to its compelling market position and potential upside. With..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A Healthcare Giant with 15% Potential Upside

IQVIA Holdings, Inc. (NYSE: IQV) stands as a formidable player in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $37.58 billion,..

Pfizer, Inc. (PFE) Stock Analysis: Evaluating a 13.63% Potential Upside in a Challenging Market

Pfizer, Inc. (NYSE: PFE) remains a cornerstone of the healthcare sector, renowned for its extensive portfolio of biopharmaceutical products and a legacy dating back to 1849...

Insmed Incorporated (INSM) Investor Outlook: Strong Revenue Growth Amidst High Potential Upside

Investors looking to capitalize on the biotechnology sector’s promising landscape should turn their attention to Insmed Incorporated (NASDAQ: INSM). With a significant market cap of $37.29..

Fresenius Medical Care AG (FMS) Stock Analysis: Exploring a 22.33% Potential Upside for Investors

Fresenius Medical Care AG (NYSE: FMS), headquartered in Bad Homburg, Germany, is a key player in the healthcare sector, specifically within the medical care facilities industry...

Illumina, Inc. (ILMN) Stock Analysis: A Look at Growth Potential Amidst Mixed Analyst Ratings

Illumina, Inc. (NASDAQ: ILMN) stands at the intersection of healthcare innovation and genetic research, offering advanced sequencing and array-based solutions to a global market. As a..

Biogen Inc. (BIIB)

⚠️ No article content returned.

..

Labcorp Holdings Inc. (LH) Stock Analysis: Unpacking a 19% Potential Upside for Investors

Labcorp Holdings Inc. (NYSE: LH) stands at a fascinating juncture, offering a wealth of opportunities for investors seeking exposure in the healthcare sector, particularly within diagnostics..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds